Carol Bye

Carol Bye is a pharmaceutical executive with over 25 years of experience in the industry. Carol currently serves as the Vice President of Regulatory Quality Assurance at Pfizer. In this role, they are responsible for overseeing the quality of Pfizer's research and development initiatives as well as its medical functions worldwide.

Prior to their current role, Carol served as the Vice President of Quality Assurance GMP at Pfizer. In this role, they were responsible for quality oversight of both internal and contract manufacturing of biologics, vaccines, devices, and small molecule products. During their time in this role, they also had significant interaction with various regulatory agencies.

Before joining Pfizer, Carol held various roles at AstraZeneca, including Senior Process Engineer and Technical Leadersip roles in manufacturing and quality assurance.

Carol Bye holds a BEng in Chemical Engineering from University College Dublin.

Carol Bye reports to Rady Johnson, EVP, Chief Compliance, Quality & Risk Officer. Some of their coworkers include Sue Diviney - VP, Office of the Ombuds Lead, Guy Delp - VP, Global Information Security, and Lev Kubiak - VP, Chief Security Officer.